183 related articles for article (PubMed ID: 2684039)
1. Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.
Dolan G; Lilleyman JS; Richards SM
Arch Dis Child; 1989 Sep; 64(9):1231-4. PubMed ID: 2684039
[TBL] [Abstract][Full Text] [Related]
2. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
Chessells JM; Durrant J; Hardy RM; Richards S
J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
[TBL] [Abstract][Full Text] [Related]
3. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
Eden OB; Lilleyman JS; Richards S; Shaw MP; Peto J
Br J Haematol; 1991 Jun; 78(2):187-96. PubMed ID: 2064956
[TBL] [Abstract][Full Text] [Related]
4. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
Chessells JM; Bailey C; Richards SM
Lancet; 1995 Jan; 345(8943):143-8. PubMed ID: 7823668
[TBL] [Abstract][Full Text] [Related]
5. Analysis of treatment in childhood leukaemia. I. Predisposition to methotrexate-induced neutropenia after craniospinal irradiation. Report to the Medical Research Council of the Working Party on Leukaemia in Childhood.
Br Med J; 1975 Sep; 3(5983):563-6. PubMed ID: 1100179
[TBL] [Abstract][Full Text] [Related]
6. Medical Research Council leukaemia trial, UKALL VII. A report to the Council by the Working Party on Leukaemia in Childhood.
Arch Dis Child; 1985 Nov; 60(11):1050-4. PubMed ID: 3907505
[TBL] [Abstract][Full Text] [Related]
7. Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapy.
MacLennan IC; Kay HE; Festenstein M; Smith PG
Br J Haematol; 1976 Jun; 33(2):179-88. PubMed ID: 1063593
[TBL] [Abstract][Full Text] [Related]
8. Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
Chessells JM; Harrison G; Lilleyman JS; Bailey CC; Richards SM
Br J Haematol; 1997 Sep; 98(4):945-51. PubMed ID: 9326194
[TBL] [Abstract][Full Text] [Related]
9. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
10. Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study).
Pinkerton CR; Bowman A; Holtzel H; Chessells JM
Arch Dis Child; 1987 Jan; 62(1):12-8. PubMed ID: 3468886
[TBL] [Abstract][Full Text] [Related]
11. Improvement in treatment for children with acute lymphoblastic leukaemia. The Medical Research Council UKALL trials, 1972-84. Report to the Council by the Working Party on Leukaemia in Childhood.
Lancet; 1986 Feb; 1(8478):408-11. PubMed ID: 2868339
[TBL] [Abstract][Full Text] [Related]
12. Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia.
Lennard L; Rees CA; Lilleyman JS; Maddocks JL
Br J Clin Pharmacol; 1983 Oct; 16(4):359-63. PubMed ID: 6578834
[TBL] [Abstract][Full Text] [Related]
13. Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: better in the evening.
Rivard GE; Infante-Rivard C; Hoyoux C; Champagne J
Lancet; 1985 Dec; 2(8467):1264-6. PubMed ID: 2866334
[TBL] [Abstract][Full Text] [Related]
14. The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse.
Schmiegelow K; Heyman M; Gustafsson G; Lausen B; Wesenberg F; Kristinsson J; Vettenranta K; Schroeder H; Forestier E; Rosthoej S;
Leukemia; 2010 Apr; 24(4):715-20. PubMed ID: 20130603
[TBL] [Abstract][Full Text] [Related]
15. Treatment of childhood acute lymphoblastic leukemia in Malaysia, 1976-1982.
Lin HP; Sinnah D; Menaka N; Cherian R; Singh P
Med Pediatr Oncol; 1983; 11(5):327-32. PubMed ID: 6579342
[TBL] [Abstract][Full Text] [Related]
16. Excessive chemotherapy-related myelotoxicity in children with Down syndrome and acute lymphoblastic leukaemia.
Blatt J; Albo V; Prin W; Orlando S; Wollman M
Lancet; 1986 Oct; 2(8512):914. PubMed ID: 2876340
[No Abstract] [Full Text] [Related]
17. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
[TBL] [Abstract][Full Text] [Related]
18. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
Clavell LA; Gelber RD; Cohen HJ; Hitchcock-Bryan S; Cassady JR; Tarbell NJ; Blattner SR; Tantravahi R; Leavitt P; Sallan SE
N Engl J Med; 1986 Sep; 315(11):657-63. PubMed ID: 2943992
[TBL] [Abstract][Full Text] [Related]
19. Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia.
Vang SI; Schmiegelow K; Frandsen T; Rosthøj S; Nersting J
Cancer Chemother Pharmacol; 2015 May; 75(5):1089-93. PubMed ID: 25788208
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute lymphoblastic leukaemia: effect of "prophylactic" therapy against central nervous system leukaemia. Report ot the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1973 May; 2(5863):381-4. PubMed ID: 4574042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
